Lymphadenopathy News and Research

RSS
Lymphadenopathy refers to the enlargement of one or more lymph nodes, the bean-shaped glands found in the neck, armpits, chest, groin, and abdomen. Lymphadenopathy may occur in just one part of the body, in which case it is referred to as “localized” or it may be present in two or more body areas, in which case it is referred to as “generalized.” The condition most commonly affects nodes in the neck (cervical lymph nodes).
Study reveals how a regulatory molecule ensures appropriate supply of blood cells

Study reveals how a regulatory molecule ensures appropriate supply of blood cells

Celgene to share new and updated data around novel hematological therapies

Celgene to share new and updated data around novel hematological therapies

CE marked MAST Toxoreagent kit for detection of Toxoplasma antibodies

CE marked MAST Toxoreagent kit for detection of Toxoplasma antibodies

Tattoo ink from 15 years ago mimics lymph node cancer: Case study

Tattoo ink from 15 years ago mimics lymph node cancer: Case study

Zinbryta gets FDA approval for treating adults with relapsing forms of MS

Zinbryta gets FDA approval for treating adults with relapsing forms of MS

Post-treatment imaging can help detect recurrences of HPV-positive oropharyngeal cancer

Post-treatment imaging can help detect recurrences of HPV-positive oropharyngeal cancer

Training advised to plug lung cancer care gaps

Training advised to plug lung cancer care gaps

Phase 3 study of idelalisibin reports positive results in CLL patients

Phase 3 study of idelalisibin reports positive results in CLL patients

Brake for skin inflammation discovered

Brake for skin inflammation discovered

Article describes immune-related adverse events with newly approved melanoma drug

Article describes immune-related adverse events with newly approved melanoma drug

Positive results from XIAFLEX phase IIIb multicord trial for Dupuytren's contracture

Positive results from XIAFLEX phase IIIb multicord trial for Dupuytren's contracture

FDA approves XenoPort, GSK’s Horizant ER tablets for management of PHN

FDA approves XenoPort, GSK’s Horizant ER tablets for management of PHN

Gilead commences GS-1101 Phase 3 trial in CLL

Gilead commences GS-1101 Phase 3 trial in CLL

Rheumavax safe and feasible in treating RA

Rheumavax safe and feasible in treating RA

Study explains why some people experience repeated infections of Lyme disease

Study explains why some people experience repeated infections of Lyme disease

Rwanda, QIAGEN and Merck launch comprehensive national cervical cancer prevention program

Rwanda, QIAGEN and Merck launch comprehensive national cervical cancer prevention program

Positive results from Nabriva's BC-3781 Phase II trial in ABSSSI

Positive results from Nabriva's BC-3781 Phase II trial in ABSSSI

Boehringer Ingelheim receives FDA approval for Viramune XR to treat HIV-1 infection

Boehringer Ingelheim receives FDA approval for Viramune XR to treat HIV-1 infection

Merck announces publication of GARDASIL pivotal Phase III study data in NEJM

Merck announces publication of GARDASIL pivotal Phase III study data in NEJM

Merck announces FDA approval for GARDASIL against HPV-related anal cancer

Merck announces FDA approval for GARDASIL against HPV-related anal cancer